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Purpose: The purpose of this study was to evaluate the permeability of the blood–brain   barrier 
after sonication by pulsed high-intensity focused ultrasound and to determine if such an approach 
increases the tumor:ipsilateral brain permeability ratio.
Materials and methods: F98 glioma-bearing Fischer 344 rats were injected intravenously 
with Evans blue with or without blood–tumor barrier disruption induced by transcranial pulsed 
high-intensity focused ultrasound. Sonication was applied at a frequency of 1 MHz with a 
5% duty cycle and a repetition frequency of 1 Hz. The permeability of the blood–brain bar-
rier was assessed by the extravasation of Evans blue. Contrast-enhanced magnetic resonance 
images were used to monitor the gadolinium deposition path associated with transcranial pulsed 
high-intensity focused ultrasound, and the influencing size and location was also investigated. 
In addition, whole brain histological analysis was performed. The results were compared by 
two-tailed unpaired t-test.
Results: The accumulation of Evans blue in brains and the tumor:ipsilateral brain permeability 
ratio of Evans blue were significantly increased after pulsed high-intensity focused ultrasound 
exposure. Evans blue injection followed by sonication showed an increase in the tumor:ipsilateral 
brain ratio of the target tumors (9.14:1) of about 2.23-fold compared with the control tumors 
(x4.09) on day 6 after tumor implantation. Magnetic resonance images showed that pulsed 
high-intensity focused ultrasound locally enhances the permeability of the blood–tumor barrier 
in the glioma-bearing rats.
Conclusion: This method could allow enhanced synergistic effects with respect to other brain 
tumor treatment regimens.
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Introduction
A significant number of advances have recently been made in agents for the chemo-
therapeutic treatment of brain tumors, but the blood–brain barrier (BBB) often prevents 
cytotoxic levels being achieved. The survival of patients with malignant glioma is on 
average less than 2 years, even after surgical resection and extensive treatment using 
chemotherapy and high-dose irradiation.1,2 New therapeutic modalities that improve 
the life expectancy of these patients are critically needed. Although the blood–tumor 
barrier (BTB) is more permeable than the BBB, malignancies of the brain remain 
hard to treat with chemotherapy because the selective permeability of the BTB still 
blocks many agents from reaching their target.3 Therefore, the efficacy of therapeutic 
agents will be improved and any side effects minimized if an approach is available 
that allows the efficient delivery of a therapeutic dose to a planned target volume 
without harming the brain.
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Despite the fact that the integrity of the BBB is often 
reduced near a brain tumor, antitumor agents are rarely effec-
tive in patients with brain tumors because of the BTB.4 The 
regions of BBB disruption that occur in tumors, if they occur 
at all, are generally near the tumor center; this region has been 
found to generally have a higher permeability than normal 
brain. The BBB in the tissues surrounding brain tumors 
and at the peripheral margin of the brain tumor are usually 
intact. However, malignant cells may have already invaded 
these areas. Therefore, in order to improve the efficacy of 
treatments of malignant glioma, drugs need to be delivered 
not only to tumor cells in the central region where the BTB 
has broken down but also where the migrating tumor cells 
are infiltrating the intact regions.
Many approaches have been tried to enhance the delivery 
of drugs to brain tumors but these have met with limited suc-
cess. Chemotherapy accompanied by biochemical or osmotic 
BBB disruption may moderately augment the delivery of 
drugs to the brain.5,6 A solution of mannitol produces a hyper-
osmotic environment in which the BBB endothelial cells are 
temporarily dehydrated and therefore shrink, which opens 
the tight junctions and so temporarily disrupts the BBB. Our 
previous study has demonstrated that after BBB disruption 
by injection of mannitol the concentration of boron in tumors 
and the tumor:normal brain ratio of boron are significantly 
higher than that without BBB disruption.7 However, these 
methods require intra-arterial catheterization and produce 
nonfocal BBB disruption within the entire tissue volume 
supplied by the injected artery branch.8,9
Pulsed high-intensity focused ultrasound (HIFU) has been 
shown to locally and reversibly increase the permeability of 
the BBB, and these changes to the BBB are affected by the 
applied pressure amplitude and dose of ultrasound contrast 
agent (UCA).10–12 Pulsed HIFU can produce mechanical 
effects that increase the permeability of the sonicated tis-
sue in a noninvasive manner. Previous studies have shown 
that enhanced delivery of various chemotherapeutic agents 
to tumors occurs after pulsed HIFU and that this improves 
their antitumor effects.13 The purpose of this study was to 
investigate the use of pulsed HIFU to enhance delivery of 
a relatively large amount of drugs to gliomas during tumor 
progression and determine if such an approach increases the 
tumor:ipsilateral brain ratio.
Materials and methods
F98 glioma brain tumor model
All animal experiments were performed according to 
the appropriate guidelines and approved by the National 
Yang-Ming University’s Animal Care and Use   Committee. 
Male Fischer 344 rats (9–12 weeks, approximately 
290–340 g) were anesthetized by an intraperitoneal admin-
istration of pentobarbital at a dose of 40 mg/kg of body 
weight. Then 1 × 105 F98 rat glioma cells in 10 µL Hanks’ 
balanced salt solution without Mg2+ and Ca2+ were injected 
into the brains of the rats. The glioma cells were stereotacti-
cally injected into one location in each hemisphere (5.0 mm 
posterior and 3.0 mm lateral to the bregma) of each rat’s 
brain at a depth of 5.0 mm from the brain surface. Next, 
the holes in the skull were sealed with bone wax and the 
wound was flushed with iodinated alcohol. The twenty-seven 
glioma-bearing rats were randomly divided into 3 groups. All 
rats in groups 1 and 2 were sonicated, group 1 was used for 
Evans blue (EB), and groups 2 and 3 were used for magnetic 
resonance (MR) imaging and histology.
Pulsed HIFU system and sonication
The pulsed HIFU was generated by a 1 MHz single-element 
focused transducer (A392S, Panametrics, Waltham, MA) 
with a diameter of 38 mm and a radius of curvature of 
63.5 mm. The half-maximum of the pressure amplitude of 
the focal zone had a diameter and length of 3 mm and 26 mm, 
respectively. The whole system has been described in detail 
in our previous report.14
The rat’s head was mounted on the stereotaxic apparatus 
with the nose bar positioned 3.3 mm below the interaural 
line. UCA (SonoVue, Bracco International, Amsterdam, The 
Netherlands) was injected into the femoral vein of the rats 
approximately 15 seconds before each sonication. The UCA 
contains phospholipid-coated microbubbles with a mean 
diameter of 2.5 µm, and at a concentration of 1 × 108 to 5 × 108 
bubbles/ml. Sonication was pulsed with a burst length of 
50 ms at a 5% duty cycle and a repetition frequency of 1 Hz. 
The duration of the sonication was 60 seconds. The pulsed 
HIFU was delivered to one location in the right   hemisphere of 
the brain at the location of tumor cell implantation. For all of 
the animal experiments, the rats were sonicated after an injec-
tion of 300 µL/kg UCA at an acoustic power of 5.72 W.
Assessment of BBB disruption
The permeability of the BBB can be quantified based on 
the extravasation of EB, which acts as a marker of albumin 
extravasation.11,14,15 EB (Sigma, St Louis, MO) (100 mg/kg) 
was injected intravenously approximately 5 minutes before 
pulsed HIFU exposure. The animals were sacrificed 
  approximately 30 minutes after the sonication (Figure 1). 
The rats were perfused with saline via the left ventricle until 
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colorless perfusion fluid appeared from the right atrium. After 
perfusion and brain removal, the hemispheres of the brain were 
dissected into tumor tissue and normal brain tissue before mea-
suring the amount of EB extravasation. The left unsonicated 
brains acted as the controls. Samples were weighed and then 
soaked in 50% trichloroacetic acid solution. After homogeni-
zation and centrifugation, the extracted dye was diluted with 
ethanol (1:3), and the amount of dye present measured using 
a spectrophotometer (PowerWave 340, BioTek, Winooski, 
VT) at 620 nm. The EB present in the tissue samples was 
quantified using a linear regression standard curve derived 
from seven concentrations of the dye; the amount of dye was 
denoted in absorbance per gram of tissue. Results are typically 
expressed as means ± standard error of the mean. Any differ-
ences in EB concentration were analyzed by t-test. Statistical 
significance was defined as a P value # 0.05.
MR imaging
Magnetic resonance imaging (MRI) of the glioma-bearing 
rats was performed using a 3T MRI system (TRIO 3-T 
MRI, Siemens AG MAGNETOM, Erlangen, Germany). 
A loop coil (Loop Flex Coil, small, approximately 4 cm in 
diameter; Siemens AG) for radio frequency reception was 
used. Each rat was injected intravenously with 1 mmol/kg 
of gadolinium (Gd-DTPA, Omniscan, GE Healthcare, Cork, 
Ireland) immediately after sonication. The rats were anesthe-
tized with 1.5% isoflurane mixed with O2, and maintained 
on 1% isoflurane during the imaging procedure. A multislice 
spin echo sequence was performed to obtain 20 slices of the 
T1-weighted MR image covering the whole brain in order 
to monitor BBB disruption. The imaging plane was located 
across the tumor at the depth of the tumor center. In addition, 
tumor volumes were assessed from T2-weighted images by 
adding the tumor area measured from each slice and multi-
plying by the slice thickness (1 mm). The parameters for the 
MRI scans are listed in Table 1. MRI contrast enhancement 
was analyzed 30 minutes after the gadolinium injection. 
The contour maps describing the spatial distribution of the 
contrast enhancement were quantified in a second group of 
experiments. For each rat, the regions of contrast enhance-
ment above four, eight, twelve, and 16 standard deviations of 
the averaged spatial normal brain regions were color-coded, 
allowing the distinguishable features to be easily observed.
Histological observations
After the MRI scanning, the second group of rats was prepared 
for histological evaluation. The rat was perfused with saline 
and 10% neutral buffered formalin. The brain was removed 
and embedded in paraffin and then serially sectioned into 6 µm 
slices. The slices were stained with hematoxylin-eosin (H&E) 
in order to confirm tumor progression.   Terminal deoxynucle-
otidyl transferase dUTP nick end labeling (TUNEL) staining 
(DeadEnd Colorimetric TUNEL system, G7130, Promega, 
Madison, WI) was used for the detection of DNA fragmenta-
tion and apoptotic bodies in the cells. The histological evalu-
ation was carried out by light microscopy (Olympus BX61, 
Olympus, Shinjuku-Ku, Tokyo, Japan).
Results
Body weight and tumor progression
The rats’ mean body weight was greatest immediately after 
tumor implantation and decreased as a function of time due 
to growth of the tumor. Compared to the first day following 
tumor implantation, the mean body showed no obvious dif-
ference on day 6. However, it was significantly decreased 
on day 8 and had declined rapidly by day 12 (Figure 2). 
Evans blue Microbubble
Sonication Heart perfusion
5 min 15 sec 60 sec 30 min
Figure 1 Experimental time line for BTB disruption. EB was injected intravenously several minutes before sonication. Pulsed HIFU was applied 15 seconds after UCA 
administration in the right hemispheres. Rats were perfused 30 minutes after sonication to allow EB quantification.
Abbreviations: EB, Evans blue; HIFU, high-intensity focused ultrasound; UCA, ultrasound contrast agent.
Table 1 MRI parameters used in this study
Sequence Purpose Repetition time (ms) Echo time (ms) Matrix Slice thickness (mm)
SE T1-W Contrast enhancement 500 13 243 × 512 1
T2-W Tumor volume 6690 104 243 × 512 1
Abbreviation: MRI, magnetic resonance imaging.
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The permeability of the BTBs was therefore assessed in rat 
brains on days 6, 8, and 12 after tumor cell implantation. 
Tumor progression was evaluated in terms of weight and 
volume (Figure 3A and B). The mean tumor weight and 
tumor   volume at day 12 were significantly greater than on 
day 6 or day 8. The mean tumor volume of the day 8 group 
was significantly greater than those of the day 6 group, but 
no significant difference in mean tumor weight was evident 
between the day 6 and day 8 groups.
Assessment of EB extravasation
The BBB disrupted region was observed to occur in the focal 
zone of the ultrasound beam as assessed by EB extravasation. 
Figure 4 illustrates the degree of EB staining in the right and 
left hemispheres with and without sonication at the three 
time points after tumor implantation. Both the size and color 
intensity of the EB staining increased with tumor progres-
sion and that of the sonicated right hemispheres was greater 
than the nonsonicated left hemispheres for the three chosen 
days following tumor implantation. Figure 5 shows the mean 
extravasation of EB per unit mass (in micrograms per gram 
of tissue) for the brain tumors and the neighboring normal 
brain tissues with or without sonication at three time points 
after tumor implantation. EB extravasation was quantified in 
each tumor-implanted hemisphere brain; both the sonicated 
tumor and contralateral unsonicated control tumor were 
examined. Not only was the permeability of the control tumor 
BBB significantly greater than that of the adjacent normal 
brain region, but it was also found that the BTB disruption 
was significantly greater at the tumor site after sonication 
than in the control tumor for all three days. Pulsed HIFU 
exposure administered after EB introduction increased 
the EB   concentration in the tumor by 805%, 580%, and 274% 
on days 6, 8, and 12, respectively (Figure 6A). There was 
no obvious difference in the derived tumor:ipsilateral brain 
ratios in the control tumor across the three days. Importantly, 
however, the derived tumor:ipsilateral brain ratios were 
greater after sonication than without sonication for all days; 
this change was significant on day 6 and day 8 (Figure 6B). 
The detailed ratios are listed in Table 2.
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Figure 2 Mean body weight in grams of glioma-bearing rats during tumor progression.
Notes: *P , 0.05; **P , 0.01.
Figure 3 Mean tumor weight (A) (0.009 ± 0.003, 0.012 ± 0.003, 0.034 ± 0.007 g) 
and tumor volume (B) (0.02 ± 0.01, 0.06 ± 0.01, 0.17 ± 0.02 cm3) in glioma-bearing 
rats on days 6, 8, and 12 after tumor implantation.
Notes: *P , 0.05; **P , 0.01.
0.00
68
Day
T
u
m
o
r
 
w
e
i
g
h
t
 
(
g
)
10
*
**
12
0.01
0.02
0.03
0.04
0.05
0.06 A
6
0.00
0.05
0.10
0.15
0.20
0.25 B
8
T
u
m
o
r
 
v
o
l
u
m
e
 
(
c
m
3
)
10 12
**
**
*
Figure  4  Distribution  of  BBB  disruption  for  brain  tumors  as  evaluated  by 
extravasation of EB into the brain. Right brain: tumor with pulsed HIFU exposure. 
Left brain: control tumor without pulsed HIFU exposure. The tumor area and 
sonication path are consistent with the MR images in Figure 7A.
Abbreviations:  BBB,  blood–brain  barrier;  EB,  Evans  blue;  HIFU,  high-intensity 
focused ultrasound; MR, magnetic resonance.
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Figure 5 Concentration of EB in the tumor and neighboring normal brain regions 
with and without sonication. The EB extravasation in the brain tumor with sonication 
was significantly higher than in brain tumor without sonication. Compared with 
normal tissues neighboring the control tumors, there was a significant difference for 
the control tumors and for the neighboring normal tissues of sonicated tumors on 
all days and on days 6 and 8, respectively.
Notes: *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviation: EB, Evans blue.
Figure 6 The ratio of EB concentration between sonicated tumor and control 
tumor (A) and the derived tumor:ipsilateral brain ratios after sonication and without 
sonication (B) during tumor progression.
Abbreviation: EB, Evans blue.
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Table 2 Tumor:ipsilateral normal brain ratios
Day after implantation Ratio of tumor to brain
Pulsed HIFU Control
Mean SEM Mean SEM
6 9.14* 1.13 4.09 0.89
8 7.36* 1.21 3.72 0.96
12 5.52† 1.12 3.86 0.57
Notes: *Significant (P , 0.05) difference compared with control group; †significant 
(P , 0.05) difference compared with pulsed HIFU tumor on day 6.
Abbreviations: HIFU, high-intensity focused ultrasound; SEM, standard error of 
the mean.
MRI analysis and histology
MRI studies were carried out in a subset of animals to 
noninvasively quantify tumor growth as a function of time; 
furthermore, the sonication pathway can be monitored using 
MR images in the right sonicated hemispheres (Figure 7A). 
In addition, the corresponding H&E and TUNEL-stained 
sections were observed for tumor progression and apoptotic 
evaluation (Figure 7B and C). Based on the histological 
observations, tumor progression was consistent with the 
MR images and no significant difference in apoptosis was 
found between the sonicated and control tumors. To better 
understand the extent of deposition of gadolinium, the con-
tour maps of the spatial distribution of gadolinium for tumors 
with and without sonication are presented in Figure 8. The 
contrast-enhanced regions in the right sonicated tumor were 
greater than in the left control tumor, especially for tumors 
on day 6 and day 8. During histological analysis of the soni-
cated and control tumors, local displacement and increased 
Figure  7  Images  of  the  tumors  with  and  without  pulsed  HIFU  exposure  by 
(A)  T1-weighted  MR  images,  (B)  hematoxylin-eosin-stained  sections,  and 
(C) TUNEL staining on days 6, 8, and 12 after implantation. The tumor progression 
and sonication pathway can be monitored in the MR images. H&E and TUNEL 
stained sections were observed for histology and apoptotic evaluation.
Abbreviations: H&E, hematoxylin-eosin; HIFU, high-intensity focused ultrasound; 
MR, magnetic resonance; TUNEL, terminal deoxynucleotidyl transferase dUTP nick 
end labeling.
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extravasation of red blood cells were seen in the sonicated 
tumor tissues in and around the focal region (Figure 9).
Discussion
This study demonstrates that pulsed HIFU can not only signif-
icantly increase the permeability of the BTB in brain tumors, 
but also significantly elevated the tumor:brain drug ratio in the 
focal region that was elicited by an ultrasound beam passing 
through the intact skull. The brain entry of drugs is impeded 
by the BBB, even though the permeability of this barrier 
may be partially increased due to the presence of a tumor. 
However, selective delivery of chemotherapeutic agent to 
brain tumor cells across the BTB remains a major obstacle 
to many approaches to brain tumor treatment. Our previous 
studies have shown that injecting an appropriate quantity of 
UCA effectively increases and localizes the BBB disruption 
that is induced by pulsed HIFU exposure.11,14,15 In this study, a 
combination of pulsed HIFU and   microbubbles increased the 
permeability of the BTB as measured by EB   extravasation. 
The use of MRI contrast enhancement also revealed that 
this approach increased the level of gadolinium entering the 
brain tumor tissue.
The main limitation of this study was the size of the ultra-
sound beam focal zone produced by our device, which was 
not large enough to produce delivery enhancement for the 
whole tumor region on day 8 and day 12. This may be why the 
enhancement induced by pulsed HIFU decreased from day 6 
to day 12 after implantation. This phenomenon suggests that 
the permeability of the BTB is increased only locally by pulsed 
HIFU. In addition, pulsed HIFU also enhanced permeability in 
the normal brain tissue surrounding the sonicated tumor on day 6 
and day 8. Nevertheless, the enhanced uptake in the tumor tissue 
would be advantageous when treating larger tumors in humans 
using a phased array transducer for multiple focal   sonications. 
Figures 5 and 6B reveal that there were no differences in EB 
extravasation per gram of control tumor tissue or in the control 
tumor:ipsilateral brain ratio as the tumors progressed. Moreover, 
pulsed HIFU was able to significantly increase the permeability 
of the BTB and the ratio of tumor to brain, especially for the 
smaller tumors on day 6 and day 8; this was when the focal zone 
almost covered the whole tumor region.
Gadolinium deposition and the pattern of contrast 
enhancement were monitored by signal intensity level. 
  Figure 8 shows that these are larger at high intensity level 
sites in the sonicated tumor on all days, especially on 
day 6 and day 8. This is consistent with the EB extravasa-
tion results. The sonication pathway can be observed from 
the brain   surface to the bottom of the brain (Figure 8A). 
  Additionally, the pattern of contrast enhancement while 
the pulsed HIFU beam is targeted over a non-homogeneous 
tumor tissue does not correspond to the circular pattern of 
the ultrasound beam on the cross section (Figure 8B).
One recent study has demonstrated that sonication after 
EB injection can lead to nearly a fivefold increase in EB 
extravasation in target hepatocellular carcinoma compared 
with contralateral controls. However, this effect is reduced 
while EB is administered after sonication.16 If the previous 
hypothesis is correct, then pulsed HIFU should be able to be 
used for the enhancement of local drug delivery when there 
Figure 8 In vivo magnetic resonance images of rats bearing F98 gliomas in the 
(A)  coronal  view  and  (B)  axial  view.  The  spatial  distribution  of  brain  tumor 
BBB  disruption  with  and  without  sonication  in  the  right  and  left  hemispheres, 
respectively, is shown. The rat brains were analyzed 30 minutes following gadolinium 
administration. Regions of contrast enhancement .4, .8, .12, and .16 standard 
deviations above the average MRI signal intensity of the normal brain tissue are 
shown in green, yellow, blue, and red respectively .
Abbreviations: BBB, blood–brain barrier; MRI, magnetic resonance imaging.
Figure 9 The structure of the contralateral brain tumor without sonication (A and 
C) and of the brain tumor tissue with sonication (B and D) by H&E staining (original 
magnification × 100 from Figure 7B; scale bar = 200 µm). Local displacement and 
increased extravasation of red blood cells were indicated by arrows in the sonicated 
tumor tissues in and around the focal region.
Abbreviation: H&E, hematoxylin-eosin.
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is a transient increase in capillary permeability. Therefore, the 
present study was performed using pulsed HIFU after EB injec-
tion in order to elevate extravasation of EB in the brain tumor 
tissue as much as possible. Furthermore, both focused and 
unfocused ultrasound exposure have previously been shown to 
produce a widening of intercellular gaps.17,18 Compared with 
the control tumors (Figure 9A and C), H&E staining showed 
pulsed HIFU exposure led to a widening of intercellular gaps 
and an increase in red blood cell extravasation (Figure 9B 
and D). Thus, the driving force behind the induction of BTB 
disruption by sonication may be increased drug extravasation 
due to presence of large gaps in the endothelium.19
Many methods having been tested to facilitate drug deliv-
ery through the disruption of the BTB, but none have been 
practical when applied clinically. For instance, the BTB has 
been shown to be disrupted after an intracarotid artery injec-
tion of a hyperosmotic solution such as mannitol using boron 
neutron capture therapy. Nevertheless, due to restrictions on 
drug brain entry by the BTB and BBB, the selective delivery 
of a drug to individual brain tumor cells or the tissues sur-
rounding brain tumors remains one of the major challenges 
to the boron neutron capture therapy of brain tumors, and 
many approaches have been reported.20 Another study dem-
onstrated that pulsed HIFU increased the uptake of antibody 
into surrounding tissue, but the net increase was marginal.21 
The current research has shown that completely noninvasive 
focal disruption of the BTB in the tumor and BBB in the 
adjacent normal brain tissue is possible through pulsed HIFU. 
Figure 6B indicates that BTB disruption induced by sonica-
tion causes a 2.23-fold increase in the tumor:ipsilateral brain 
ratio for EB in the target tumors compared with the control 
tumors. The results of this pilot study therefore suggest that the 
further evaluation of other treatment strategies is warranted – 
this may include multiple sonications to increase delivery of 
chemotherapeutic agents to larger brain tumors.
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